ArticleFrontiers in drug safety and regulation2023

Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination.

Takahiro Niimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.